SLCO1B1 and myopathy: Variants in SLCO1B1 are associated with myopathy in particular when there is a documentedincrease in creatinine kinase concentration in blood.3,39 A poor function phenotype of OATP1B1 can increase the probabilityfor adverse effects during statin treatment, thus reducing medicationadherence.